Roger Kornberg

Roger Kornberg

Président chez COCRYSTAL PHARMA, INC.

Fortune : 60 282 $ au 31/05/2026

79 ans
Health Technology
Consumer Services
Commercial Services

Profil

Roger David Kornberg is the founder of Metha Artificial Intelligence Ltd, founded in 2022.
Dr. Kornberg is the founder of Cocrystal Discovery, Inc., founded in 2008, and held the title Director & Chief Scientist.
Dr. Kornberg is the founder of Neotx Holdings Ltd., founded in 2015, and holds the title Chairman.
Dr. Kornberg is also the founder of Cognos Therapeutics, Inc.,InterX, Inc...
Dr. Kornberg is currently Chairman at Cocrystal Pharma, Inc. since 2021.
Dr. Kornberg is Chairman at Autonomous Medical Devices, Inc. Dr. Kornberg is Independent Non-Executive Director at Xenetic Biosciences, Inc. since 2016.
Dr. Kornberg is Director at Gamida Cell, Inc. Dr. Kornberg is Director at Annual Reviews.
Dr. Kornberg is Professor at Stanford University since 1978.
Dr. Kornberg is Member of the National Academy of Sciences.
Dr. Kornberg is Member of the American Academy of Arts & Sciences.
Dr. Kornberg is Professor at Stanford University School of Medicine since 1978.
Dr. Kornberg is Advisor at Teal Ventures Management LLC.
Former positions include Director at Teva Pharmaceutical Industries Ltd. from 2007 to 2013.
Director at Arrowhead Pharmaceuticals, Inc. Independent Director at OphthaliX, Inc. Director at Protalix Biotherapeutics, Inc. from 2008 to 2012.
Director at Gamida Cell Ltd. from 2017 to 2019.
Director & Chief Scientist at BioZone Pharmaceuticals, Inc. in 2014.
Director at NDFOS Co., Ltd. Foreign Member of The Royal Society.
Assistant Professor at Harvard Medical School.
Education includes undergraduate degree from Harvard University in 1967 and doctorate from Stanford University in 1972.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/01/2026 53 823 ( 0,39% ) 60 282 $ 31/05/2026
31/12/2025 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Roger Kornberg

SociétésPosteDébut
COCRYSTAL PHARMA, INC. Président 27/05/2021
XENETIC BIOSCIENCES, INC. Directeur/Membre du Conseil 29/02/2016
Directeur/Membre du Conseil -
Consultant / Advisor -
Fondateur -
Directeur/Membre du Conseil -
Fondateur 01/01/2015
Corporate Officer/Principal 01/01/1978
Corporate Officer/Principal 01/01/1978
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ -
░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░ -

Anciens postes connus de Roger Kornberg

SociétésPosteFin
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ -
Voir l'expérience en détail de Roger Kornberg

Formation de Roger Kornberg

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Miscellaneous

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Electronic Technology

Process Industries

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Technology Services

  1. Bourse
  2. Insiders
  3. Roger Kornberg
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT